Medtronic plc (MDT)
NYSE: MDT · IEX Real-Time Price · USD
79.48
-1.73 (-2.13%)
At close: Jul 19, 2024, 4:00 PM
79.88
+0.40 (0.50%)
Pre-market: Jul 22, 2024, 7:34 AM EDT

Medtronic Revenue

In the fiscal year ending April 26, 2024, Medtronic had annual revenue of $32.36B with 3.64% growth. Revenue in the quarter ending April 26, 2024 was $8.59B with 0.51% year-over-year growth.

Revenue (ttm)
$32.36B
Revenue Growth
+3.64%
P/S Ratio
3.15
Revenue / Employee
$340,674
Employees
95,000
Market Cap
101.91B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 26, 202432.36B1.14B3.64%
Apr 28, 202331.23B-459.00M-1.45%
Apr 29, 202231.69B1.57B5.21%
Apr 30, 202130.12B1.20B4.16%
Apr 24, 202028.91B-1.64B-5.38%
Apr 26, 201930.56B604.00M2.02%
Apr 27, 201829.95B243.00M0.82%
Apr 28, 201729.71B877.00M3.04%
Apr 29, 201628.83B8.57B42.31%
Apr 24, 201520.26B3.26B19.15%
Apr 25, 201417.01B415.00M2.50%
Apr 26, 201316.59B406.00M2.51%
Apr 27, 201216.18B676.00M4.36%
Apr 29, 201115.51B116.00M0.75%
Apr 30, 201015.39B793.00M5.43%
Apr 24, 200914.60B1.08B8.02%
Apr 25, 200813.52B1.22B9.89%
Apr 27, 200712.30B1.01B8.92%
Apr 28, 200611.29B1.24B12.30%
Apr 29, 200510.06B967.80M10.65%
Apr 30, 20049.09B1.42B18.55%
Apr 25, 20037.67B1.25B19.57%
Apr 26, 20026.41B859.00M15.47%
Apr 27, 20015.55B535.50M10.68%
Apr 30, 20005.02B783.80M18.52%
Apr 30, 19994.23B809.40M23.65%
Apr 30, 19983.42B478.50M16.25%
Apr 30, 19972.94B772.50M35.56%
Apr 30, 19962.17B429.71M24.66%
Apr 30, 19951.74B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cigna 206.00B
Elevance Health 171.96B
HCA Healthcare 66.72B
Sanofi 51.60B
Bristol-Myers Squibb Company 45.53B
Gilead Sciences 27.45B
Boston Scientific 14.71B
Regeneron Pharmaceuticals 13.10B
Revenue Rankings